RRC ID 69470
著者 Kinoshita H, Shimozato O, Ishii T, Kamoda H, Hagiwara Y, Tsukanishi T, Ohtori S, Yonemoto T.
タイトル The Thioredoxin Reductase Inhibitor Auranofin Suppresses Pulmonary Metastasis of Osteosarcoma, But Not Local Progression.
ジャーナル Anticancer Res
Abstract BACKGROUND/AIM:Auranofin (AUR), a thioredoxin reductase (TXNRD) inhibitor, shows anticancer activity against several cancers. This study investigated the effects of AUR on the local progression and pulmonary metastasis of osteosarcoma (OS).
MATERIALS AND METHODS:Publicly available expression cohorts were analysed to study the relationship between TXNRD-2 expression and the survival of patients with OS. The murine OS cell line LM8 was stimulated with AUR. Cell viability, apoptosis-related protein levels, caspase activity, and wound healing were analysed. Tumor progression and pulmonary metastasis were investigated in C3H mice implanted with LM8 cells.
RESULTS:High-level expression of TXNRD-2 represented a negative prognostic factor for metastasis and overall survival in patients with OS. AUR induced apoptosis of OS cells via the oxidative stress-MAPK-Caspase 3 pathway, and suppressed the migration of OS cells. AUR inhibited the pulmonary metastasis of OS, but not local progression.
CONCLUSION:AUR represents a potential therapeutic drug for suppressing pulmonary metastasis of OS.
巻・号 41(10)
ページ 4947-4955
公開日 2021-10-1
DOI 10.21873/anticanres.15308
PII 41/10/4947
PMID 34593442
MeSH Animals Antirheumatic Agents / pharmacology Apoptosis Auranofin / pharmacology* Bone Neoplasms / drug therapy* Bone Neoplasms / metabolism Bone Neoplasms / pathology Cell Movement Cell Proliferation Female Humans Lung Neoplasms / drug therapy* Lung Neoplasms / metabolism Lung Neoplasms / secondary Mice Mice, Inbred C3H Osteosarcoma / drug therapy* Osteosarcoma / metabolism Osteosarcoma / pathology Prognosis Survival Rate Thioredoxin-Disulfide Reductase / antagonists & inhibitors* Tumor Cells, Cultured Xenograft Model Antitumor Assays
IF 1.994
リソース情報
ヒト・動物細胞 LM8(RCB1450)